Skip to content
HowShorted

Acadia Healthcare Company, Inc. short interest in 2024

In 2024, Acadia Healthcare Company, Inc.'s disclosed short interest ran from 3.39% of shares outstanding on 12 Jan 2024 to 7.18% on 31 Dec 2024, a change of +3.79 percentage points. The year's high was 7.37% on 13 Dec 2024 and its low 3.01% on 29 Feb 2024, averaging 4.58% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.53 days on 31 Jan 2024. Full history: Acadia Healthcare Company, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Acadia Healthcare Company, Inc. in 2024

2024 in figures

Start of year
3.39% (12 Jan 2024)
End of year
7.18% (31 Dec 2024)
Change
+3.79 pp
High
7.37% (13 Dec 2024)
Low
3.01% (29 Feb 2024)
Average
4.58%
Highest days to cover
7.53 (31 Jan 2024)
SEC filings marked
8

Every report in 2024

Acadia Healthcare Company, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20243.39%5.28
31 Jan 20243.49%7.53
15 Feb 20243.56%7.33
29 Feb 20243.01%4.86results (8-K), 10-K filed
15 Mar 20243.63%4.62
28 Mar 20244.05%6.06
15 Apr 20243.82%6.44
30 Apr 20243.48%5.35
15 May 20243.53%2.42results (8-K), 10-Q filed
31 May 20243.89%3.32
14 Jun 20244.32%5.17
28 Jun 20244.12%4.66
15 Jul 20243.86%5.17
31 Jul 20243.82%2.99results (8-K)
15 Aug 20243.93%3.1710-Q filed
30 Aug 20244.16%5.31
13 Sep 20244.02%4.79
30 Sep 20244.54%2.26
15 Oct 20246.00%3.15
31 Oct 20246.45%2.9210-Q filed, results (8-K)
15 Nov 20247.05%4.21
29 Nov 20247.33%4.43
13 Dec 20247.37%4.99
31 Dec 20247.18%3.41

See also: Acadia Healthcare Company, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.